11 – 20 of 62
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=""
width=""
height=""
allowtransparency="true"
frameborder="0">
</iframe>
- 2009
-
Mark
Pulse vs daily oral cyclophosphamide for induction of remission in ANCA-associated vasculitis: a randomized controlled trial
- Contribution to journal › Published meeting abstract
-
Mark
A comparison between biopsy-proven Lupus and ANCA-associated nephritis within a defined geographical area in southern Sweden
- Contribution to journal › Published meeting abstract
-
Mark
Long-term survival of ANCA-associated vasculitis
- Contribution to journal › Published meeting abstract
-
Mark
Natural autoantibodies against myeloperoxidase, protease 3 and glomerular basement membrane in normal healthy individuals
- Contribution to journal › Published meeting abstract
-
Mark
Randomized trial of rituximab vs cyclophosphamide for ANCA-associated renal vasculitis: RITUXVAS
- Contribution to journal › Published meeting abstract
-
Mark
Capture ELISA for PR3-ANCA is superior to detect and predict relapses of systemic vasculitis compared with direct ELISA
- Contribution to journal › Published meeting abstract
-
Mark
Studies of mechanisms underlying the prolonged neutrophil survival in ANCA-associated systemic vasculitis
- Contribution to journal › Published meeting abstract
-
Mark
Optimizing the Birmingham vasculitis activity scale to predict end-stage renal disease and death in ANCA-associated vasculitis
- Contribution to journal › Published meeting abstract
-
Mark
BPI-ANCA and long-term prognosis among adult CF patients: a prospective 10-year follow-up study
- Contribution to journal › Published meeting abstract
-
Mark
Giant cell arteritis in patient with systemic sclerosis
- Contribution to journal › Published meeting abstract
